Itraeonazole in the Treatment of Tinea Capitis

Cutis

Volumn 58, Issue 1, 1996, Pages 90-93

  Degreef, Hugo ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ITRACONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRESCHOOL CHILD; TINEA CAPITIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; TINEA CAPITIS; TREATMENT OUTCOME;

EID: 0030184583     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Rippon JW, ed: The Pathologic Fungi and the Pathogenic Actinomycetes, 2nd ed, Medical Mycology. Philadelphia, WB Saunders, 1982.
2. Williams DI, Marten PH: Oral treatment of ringworm with griseofulvin. Lancet 1: 212-213, 1958.
3. Jacobs PH: Treatment of fungal infections: state of the art. J Am Acad Dermatol 23: 549-551, 1990.
4. Gan VN, Petruska M, Ginsburg CM: Epidemiology and treatment of tinea capitis: ketoconazole vs. griseofulvin. Pediatr Infect Dis J 6: 46-49, 1978.
5. Martinez-Roig A, Torres-Rodriguez JM, Barlett-Coma A, et al: Double-blind study of ketoconazole and griseofulvin in dermatophytosis. Pediatr Infect Dis J 7: 3740, 1988.
6. Tanz RR, Herbert AA, Esterly NB: Treating tinea capitis: should ketoconazole replace griseofulvin? J Pediatr 112: 987-991, 1988.
7. Civatte P, Aubiniere D, Vachon D: Double-blind study of ketoconazole vs. griseofulvin in the treatment of tinea capitis and other dermatophytic infections. Presented at the 12th International Congress of Chemotherapy, Florence, Italy, July 19-24, 1981.
8. Heel RC: Dermatomycoses. In, Ketoconazole in the Management of Fungal Disease (Levine HB, ed), pp 85-87. Adis Press, Sydney, 1982.
9. Van Cutsem J, Van Gerven F, Janssen PAJ: Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev Infect Dis 9: S15-S32, 1987.
10. Thienpont D, Van Cutsem J, Borgers M: Ketoconazole in experimental candidosis. Rev Infect Dis 2: 570, 1980.
11. Van Cutsem J, Van Gerven F, Janssen PAJ: The in vitro and in vivo antifungal activity of itraconazole. In, Proceedings of an International Tele-symposium on the Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents (Fromtling RA, ed). Barcelona, JR Prous Science Publishers, 1987.
12. Sobel JD, Muller G: Comparison of itraconazole and ketoconazole in the treatment of experimental candidal vaginitis. Antimicrob Agents Chemother 26: 266, 1984.
13. Cauwenbergh G, De Doncker P: The clinical use of itraconazole in superficial and deep mycoses. Itraconazole scientific monograph. Beerse, Belgium, Janssen Pharmaceutica, 1987, pp 113-124.
14. Brown C, Caro I, Condry P, et al: Multicenter clinical evaluation of ketoconazole in the treatment of cutaneous fungal infections. Cutis 33: 578-581, 1984.
15. Cauwenbergh G: International experience with ketoconazole in dermatomycoses. In, Oral Therapy in Dermatomycoses: A Step Forward (Proceedings of a Symposium Held in Frankfurt) (Meinhof W, ed), p 27, Frankfurt, The Medicine Publishing Foundation, 1985.
16. Cauwenbergh G, Degreef H, Heykants J, et al: Pharmacokinetic profile of orally administered itraconazole in the human skin. J Am Acad Dermatol 18: 263-268, 1988.
17. Roth FJ, Blank H: The bio-assay for griseofulvin in human stratum corneum. Arch Dermatol 81: 662-666, 1960.
18. Shah VF, Riegelman S, Epstein WL: Determination of griseofulvin in skin, plasma and sweat. J Pharm Sci 61: 634-636, 1972.
19. Epstein WL, Shah VP, Riegelman S: Griseofulvin levels in stratum corneum. Study after oral administration in man. Arch Dermatol 106: 344-348, 1972.
20. Harris R, Jones HE, Artis WM: Orally administered ketoconazole: route of delivery to the human stratum corneum. Antimicrob Agents Chemother 24: 876-882, 1983.
21. Van Cutsem J, Van Gerven F: Therapeutic oral treatment with itraconazole oral solution of experimental microsporosis in cats. Efficacy and hair antifungal levels: a dose titration study. Preclinical research report, No 85, Janssen Research Foundation, 1991.